【英語タイトル】Global Breast Imaging Market Size study & Forecast, by Technology (Ionizing, Non-ionizing) By End-User (Hospitals & Clinics, Diagnostic Imaging Centers, Breast Care Centers) and Regional Analysis, 2022-2029
	・商品コード：BZW23MR039 ・発行会社（調査会社）：Bizwit Research & Consulting ・発行日：2023年3月6日 ・ページ数：約200 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後3営業日） ・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東 ・産業分野：医療

Global Breast Imaging Market is valued at approximately USD 3.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2022-2029. Breast imaging refers to the use of medical imaging techniques to visualize the internal structure of the breast tissue. It is used to screen for and diagnose breast cancer and other breast abnormalities, as well as to monitor the response of breast cancer to treatment. The Breast Imaging market is expanding because of factors such as growing prevalence of breast cancer and rising technological advancements in the field of breast imaging.

Breast Cancer is one of the world’s fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades. According to the World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years. According to the U.S. Department of Health and Human Services, in 2022, it is estimated that there will be 287,850 new cases of female breast cancer and an estimated 43,250 people will die of this disease. Another important component driving space increase is technological advancements in the field of breast imaging. In March 2021, Siemens Healthineers has introduced a new software solution that speeds up the entire reading workflow for breast imaging Mammovista B.smart. Addititonally, the Teamplay Mammo Dashboard, a tool for dashboard-based visualization of key performance indicators is introduced in the breast imaging process that serves to optimize workflow. In addition, Smart Breast Corporation announced acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. including the Dilon 6800® MBI scanner, the GammaLoc® MBI-guided biopsy,collimator, 3D Tomographic software. However, the high cost of Imaging Systems stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Breast Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of breast cancer cases in this region. According to the American Cancer Society’s, in 2023 about 297,790 new cases of invasive breast cancer will be diagnosed in women and around 43,700 women will die from breast cancer. Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as high R&D investments in breast cancer therapies, and developments in breast imaging modalities in the market space.

Major market player included in this report are:
Hologic Inc
Siemens Healthineers
GE Healthcare
Fujifilm Holdings Corporation
Canon Inc.,
Koninklijke Philips N.V
Aurora Healthcare US Corp.
Dilon Technologies, Inc.,
Delphinus Medical Technologies Inc.,
CMR Naviscan Corporation

Recent Developments in the Market:
 In April 2022, DetectedX and GE Healthcare formed an educational partnership to broaden access to DetectedX’s Radiology Online Learning Platform. The e – learning self-modules, designed to improve radiologists’ ability to correctly detect tumor area in 2D and 3D Mammography, have been shown to lower recall rates and improve cancer detection by more than 34%.

Global Breast Imaging Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology
Ionizing
Non-ionizing

By End-User
Hospitals & Clinics
Diagnostic Imaging Centers
Breast Care Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World